69458 Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices 

Secs. 1, 2, and 3; 

Secs. 10 to 15, inclusive; 

Secs. 22 to 27, inclusive. 

Containing approximately 9,210 acres. 

T. 38 S., R. 53 W., 

Secs. 1, 12, 13, and 24. 

Containing approximately 2,560 acres. 

T. 39 S., R. 53 W., 

Secs. 34, 35, and 36. 

Containing approximately 1,920 acres. 

T. 40 S., R. 53 W., 

Secs. 1 to 19, inclusive; 

Secs. 21 to 28, inclusive; 

Sec. 36. 

Containing approximately 17,896 acres. 

T. 41 S., R. 53 W., 

Secs. 1, 4, and 9; 

Secs. 11, 12, and 16. 

Containing approximately 3,840 acres. 

T. 40 S., R. 54 W., 

Secs. 7 to 34, inclusive. 

Containing approximately 17,901 acres. 

Aggregating approximately 146,693 acres. 

Notice of the decision will also be 

published four times in the Kodiak 

Daily Mirror. 

Eileen Ford, 

Land Transfer Resolution Specialist, Land 

Transfer Adjudication II Branch. 

[FR Doc. 2010–28433 Filed 11–10–10; 8:45 am] 

BILLING CODE 4310–JA–P 

DEPARTMENT OF THE INTERIOR 

Bureau of Land Management 

[CACA–048880, LLCAD060000, 

L51010000.FX0000, LVRWB09B2520] 

Notice of Availability of the Record of 

Decision for the Genesis Solar Energy 

Project and Amendment to the 

California Desert Conservation Area 

Resource Management Plan, Riverside 

County, CA 

AGENCY: Bureau of Land Management, 

Interior. 

ACTION: Notice of availability. 

SUMMARY: The Bureau of Land 

Management (BLM) announces the 

availability of the Record of Decision 

(ROD)/Approved Amendment to the 

California Desert Conservation Area 

(CDCA) Plan, the applicable Resource 

Management Plan (RMP) for the project 

site and the surrounding areas, located 

in the California Desert District. The 

Secretary of the Interior approved the 

ROD on November 4, 2010, which 

constitutes the final decision of the 

Department. 

ADDRESSES: Copies of the ROD/ 

Approved Amendment to the CDCA 

Plan are available upon request from the 

Field Manager, Palm Springs-South 

Coast Field Office, Bureau of Land 

Management, 1201 Bird Center Drive, 

Palm Springs, California 92262 or via 

the Internet at the following Web site: 

http://www.blm.gov/ca/st/en/fo/ 

palmsprings.html. 

FOR FURTHER INFORMATION CONTACT: 

Allison Shaffer, BLM Project Manager; 

telephone: (760) 833–7100; mailing 

address: 1201 Bird Center Drive, Palm 

Springs, California 92262; or e-mail: 

CAPSSolarNextEraFPL@blm.gov. 

SUPPLEMENTARY INFORMATION: Genesis 

Solar, LLC, a wholly owned subsidiary 

of NextEra Energy Resources, filed rightof-way (ROW) application CACA– 

048880 for the proposed Genesis Solar 

Energy Project (GSEP). The GSEP is a 

concentrated solar electrical generating 

facility using parabolic trough 

technology and facilities. The GSEP site 

is proposed on approximately 1,950 

acres of BLM-managed lands in 

Riverside County, California, 

approximately 27 miles east of the 

unincorporated community of Desert 

Center and 25 miles west of the 

Arizona-California border city of Blythe. 

The GSEP consists of 2 independent 

solar electric generating facilities with a 

net electrical output of 125 megawatts 

(MW) each, resulting in a total net 

electrical output of 250 MW. In addition 

to the site, the project includes a 

distribution line, an electrical 

transmission line, fiber optic lines, a 

natural gas pipeline, and an access road. 

A double circuit 230-kilovolt (kV) 

transmission line will be constructed to 

connect to the Southern California 

Edison Colorado River substation via 

the existing Blythe Energy Project 

Transmission Line between the Julian 

Hinds and Buck substations. The linear 

facilities will encumber approximately 

90 acres offsite. 

The project site is in the California 

Desert District within the planning 

boundary of the CDCA Plan, which is 

the applicable RMP for the project site 

and the surrounding areas. The CDCA 

Plan, while recognizing the potential 

compatibility of solar generation 

facilities on public lands, requires that 

all sites associated with power 

generation or transmission not already 

identified in that Plan be considered 

through the BLM’s land use plan 

amendment process. As a result, prior to 

approval of a ROW grant for the GSEP, 

the BLM must amend the CDCA Plan to 

allow the solar generating project on 

that site. The approved Amendment to 

the CDCA Plan specifically revises the 

CDCA Plan to allow for the 

development of the GSEP and ancillary 

facilities on land managed by the BLM. 

The BLM preferred alternative would 

result in the building of 2 adjacent and 

independent power block units, capable 

of generating approximately 250 MW of 

electricity, and the use of dry cooling 

technology, as well as all associated 

ancillary facilities. This 250 MW 

alternative was evaluated in the Final 

Environmental Impact Statement (EIS). 

The Notice of Availability of the Final 

EIS for the GSEP and the proposed 

CDCA Plan amendment was published 

in the Federal Register on August 27, 

2010 (75 FR 52736). 

Publication of the Notice of 

Availability for the Final EIS initiated a 

30-day protest period for the proposed 

amendment to the CDCA Plan and a 30- 

day comment period on the Final EIS. 

At the close of the 30-day period on 

September 27, 2010, 3 timely and 

complete written protests were received 

and resolved. Their resolution is 

summarized in the Director’s Protest 

Summary Report attached to the ROD. 

The proposed amendment to the CDCA 

Plan was not modified as a result of the 

protest resolution. In addition, the BLM 

received 10 comment letters on the 

Final EIS. The BLM’s responses to these 

comments are provided in Appendix 1 

of the ROD. Simultaneously with the 

protest period, the Governor of 

California conducted a 30-day 

consistency review of the proposed 

CDCA Plan amendment to identify any 

inconsistencies with the state or local 

plan, policies, or programs. The 

California Governor’s office did not 

identify inconsistencies between the 

proposed amendment to the CDCA Plan 

and state or local plan, policies, or 

programs. 

Because this decision is approved by 

the Secretary of the Interior, it is not 

subject to administrative appeal (43 CFR 

4.410(a)(3)). 

Authority: 40 CFR 1506.6. 

Robert V. Abbey, 

Director, Bureau of Land Management. 

[FR Doc. 2010–28434 Filed 11–10–10; 8:45 am] 

BILLING CODE 4310–40–P 

DEPARTMENT OF JUSTICE 

Office of Justice Programs 

[OJP (NIJ) Docket No. 1526] 

Notice of Draft NIJ Law Enforcement 

Duty Holster Selection and Application 

Guide 

AGENCY: National Institute of Justice. 

ACTION: Notice of Draft NIJ Law 

Enforcement Duty Holster Selection and 

Application Guide. 

SUMMARY: In an effort to obtain 

comments from interested parties, the 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices 69459 

U.S. Department of Justice, Office of 

Justice Programs, National Institute of 

Justice (NIJ) will make available to the 

general public the draft ‘‘NIJ Law 

Enforcement Duty Holster Selection and 

Application Guide.’’ The opportunity to 

provide comments on this document is 

open to industry technical 

representatives, law enforcement 

agencies and organizations, research, 

development and scientific 

communities, and all other stakeholders 

and interested parties. Those 

individuals wishing to obtain and 

provide comments on the draft 

document under consideration are 

directed to the following Web site: 

http://www.justnet.org. 

DATES: Comments must be received on 

or before December 13, 2010. 

FOR FURTHER INFORMATION CONTACT: 

Vanessa Castellanos, by telephone at 

202–514–5272 [Note: This is not a tollfree telephone number], or by e-mail at 

vanessa.castellanos@usdoj.gov. 

John H. Laub, 

Director, National Institute of Justice. 

[FR Doc. 2010–28431 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–18–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to 21 U.S.C. 958(i), the 

Attorney General shall, prior to issuing 

a registration under this Section to a 

bulk manufacturer of a controlled 

substance in schedule I or II, and prior 

to issuing a regulation under 21 U.S.C. 

952(a)(2) authorizing the importation of 

such a substance, provide 

manufacturers holding registrations for 

the bulk manufacture of the substance 

an opportunity for a hearing. 

Therefore, in accordance with 21 CFR 

1301.34(a), this is notice that on August 

26, 2010, Formulation Technologies 

LLC., 11400 Burnet Road, Suite 4010, 

Austin, Texas 78758, made application 

by renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

an importer of Fentanyl (9801), a basic 

class of controlled substance listed in 

schedule II. 

The company plans to import the 

listed controlled substance for analytical 

characterization, secondary packaging, 

and for distribution to clinical trial sites. 

Any bulk manufacturer who is 

presently, or is applying to be, 

registered with DEA to manufacture 

such basic class of controlled substance 

may file comments or objections to the 

issuance of the proposed registration, 

and may, at the same time, file a written 

request for a hearing on such 

application pursuant to 21 CFR 1301.43 

and in such form as prescribed by 21 

CFR 1316.47. 

Any such comments or objections 

being sent via regular mail should be 

addressed, in quintuplicate, to the Drug 

Enforcement Administration, Office of 

Diversion Control, Federal Register 

Representative (ODL), 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

must be filed no later than December 13, 

2010. 

This procedure is to be conducted 

simultaneously with, and independent 

of, the procedures described in 21 CFR 

1301.34(b), (c), (d), (e), and (f). As noted 

in a previous notice published in the 

Federal Register on September 23, 1975, 

(40 FR 43745–46), all applicants for 

registration to import a basic class of 

any controlled substances in schedule I 

or II are, and will continue to be, 

required to demonstrate to the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, that the requirements 

for such registration pursuant to 21 

U.S.C. 958(a); 21 U.S.C. 823(a); and 21 

CFR 1301.34(b), (c), (d), (e), and (f) are 

satisfied. 

Dated: November 1, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–28527 Filed 11–10–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Application 

Pursuant to Title 21 Code of Federal 

Regulations 1301.34 (a), this is notice 

that on June 16, 2010, Cerilliant 

Corporation, 811 Paloma Drive, Suite A, 

Round Rock, Texas 78665–2402, made 

application by renewal to the Drug 

Enforcement Administration (DEA) for 

registration as an importer of the basic 

classes of controlled substances listed in 

schedule I and II: 

Drug Schedule 

Cathinone (1235) ......................................................................................................................................................................................... I 

Methcathinone (1237) .................................................................................................................................................................................. I 

N–Ethylamphetamine (1475) ....................................................................................................................................................................... I 

N,N–Dimethylamphetamine (1480) ............................................................................................................................................................. I 

Fenethylline (1503) ...................................................................................................................................................................................... I 

Gamma Hydroxybutyric Acid (2010) ........................................................................................................................................................... I 

Ibogaine (7260) ........................................................................................................................................................................................... I 

Lysergic acid diethylamide (7315) ............................................................................................................................................................... I 

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) ............................................................................................................................... I 

Marihuana (7360) ........................................................................................................................................................................................ I 

Tetrahydrocannabinols (7370) ..................................................................................................................................................................... I 

Mescaline (7381) ......................................................................................................................................................................................... I 

3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................ I 

4-Bromo-2,5-dimethoxyamphetamine (7391) .............................................................................................................................................. I 

4-Bromo-2,5-dimethoxyphenethylamine (7392) .......................................................................................................................................... I 

4-Methyl-2,5-dimethoxyamphetamine (7395) .............................................................................................................................................. I 

2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................ I 

3,4-Methylenedioxyamphetamine (7400) .................................................................................................................................................... I 

3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................ I 

3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................ I 

4-Methoxyamphetamine (7411) ................................................................................................................................................................... I 

Alpha-methyltryptamine (7432) ................................................................................................................................................................... I 

Diethyltryptamine (7434) ............................................................................................................................................................................. I 

Dimethyltryptamine (7435) .......................................................................................................................................................................... I 

Psilocybin (7437) ......................................................................................................................................................................................... I 

Psilocyn (7438) ............................................................................................................................................................................................ I 

mstockstill on DSKH9S0YB1PROD with NOTICES